Your browser doesn't support javascript.
loading
Improving paediatric movement disorders care: Insights on rating scales utilization and clinical practice.
Amato, María Eugenia; Darling, Alejandra; Stovickova, Lucie; Attard, Stephen; Eggink, Hendriekje; Engelen, Marc; Freilinger, Michael; Grosso, Salvatore; Hadzsiev, Kinga; Moroni, Isabella; Nardocci, Nardo; Neubauer, David; Nicita, Francesco; Pagliano, Emanuela; Siegert, Sandy; Soler, Doriette; van de Pol, Laura A; Vasco, Gessica; Vidailhet, Marie; Willemsen, Michel Aap; Zibordi, Federica; Zorzi, Giovanna; Zumrova, Alena; Reinhard, Carola; Sevin, Caroline; Wolf, Nicole; Rodriguez-Blazquez, Carmen; Sival, Deborah A; Ortigoza-Escobar, Juan Darío.
Afiliação
  • Amato ME; Department of Paediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Darling A; Department of Paediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Stovickova L; Centre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic.
  • Attard S; Pediatric Neurology Department, Mater Dei Hospital, Malta.
  • Eggink H; Department of Neurology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands.
  • Engelen M; Department of Pediatric Neurology/Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, 1100 DD, the Netherlands.
  • Freilinger M; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Grosso S; Clinical Pediatrics, Department of Molecular Medicine and Development, University of Siena, Siena, Italy.
  • Hadzsiev K; Department of Medical Genetics, Medical School, University of Pécs, Pécs, Hungary.
  • Moroni I; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Nardocci N; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Neubauer D; Department of Child, Adolescent & Developmental Neurology, University Children's Hospital, Ljubljana, Slovenia.
  • Nicita F; Unit of Neuromuscular and Neurodegenerative Disorders, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Pagliano E; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Siegert S; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Soler D; Pediatric Neurology Department, Mater Dei Hospital, Malta.
  • van de Pol LA; Department of Child Neurology, Amsterdam UMC, Vrije Universiteit, De Boelelaan, 1117, Amsterdam, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Meibergdreef 9, Amsterdam, the Netherlands.
  • Vasco G; Unit of Neurorehabilitation, Department of Neuroscience and Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Vidailhet M; Department of Neurology, Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
  • Willemsen MA; Department of Pediatric Neurology, Donders Centre for Neuroscience, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Zibordi F; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Zorzi G; Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Zumrova A; Centre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic.
  • Reinhard C; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany; Centre for Rare Diseases, University Hospital Tübingen, Tübingen, Germany.
  • Sevin C; Pediatric Neurology Department, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
  • Wolf N; Department of Child Neurology, Amsterdam Leukodystrophy Center, Amsterdam UMC Location Vrije Universiteit Amsterdam, Emma's Children's Hospital, Boelelaan, 1117, Amsterdam, the Netherlands; Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, the Netherlands.
  • Rodriguez-Blazquez C; National Centre for Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Sival DA; Expertise Center Movement Disorders Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Pediatric Neurology, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, the Netherlands.
  • Ortigoza-Escobar JD; Department of Paediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain; U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain. Electronic address: juandario.ortigoza@sjd.es.
Eur J Paediatr Neurol ; 52: 10-19, 2024 Jun 29.
Article em En | MEDLINE | ID: mdl-38970889
ABSTRACT

AIM:

This exploratory study evaluates rating scale usage by experts from the European Reference Network for Rare Neurological Diseases (ERN-RND) for paediatric MD, considering factors like diagnosis, intellectual disability, age, and transition to adult care. The aim is to propose a preliminary framework for consistent application.

METHODS:

A multicentre survey among 25 ERN-RND experts from 10 European countries examined rating scale usage in paediatric MD, categorizing MD into acute, non-progressive, and neurodegenerative types. Factors influencing scale choice and the transition to adult care practices were analysed. A comprehensive literature search was conducted to identify the earliest age of application of these scales in paediatric patients.

RESULTS:

The study identifies various rating scales and establishes their usage frequencies for different MDs. Experts highlighted the need for standardized scales and proposed preliminary evaluation strategies based on clinical contexts. Challenges in applying scales to young, non-cooperative patients were acknowledged.

INTERPRETATION:

The study recommends developing standardized rating scales for paediatric MDs to improve evaluations and data collection. It suggests potential scales for specific clinical scenarios to better evaluate disease progression. Comprehensive, patient-centred care remains crucial during the transition to adult care, despite the identified challenges. This exploratory approach aims to enhance patient outcomes and care.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article